What This Post-Election Shift Means for Your Investments

The election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.

Click here now to watch the full briefing and prepare for what's next.

Eduardo Alvarez Biography and Net Worth

COO of Amyris

Eduardo Alvarez joined Amyris as Chief Operating Officer in October 2017. He has over 30 years of global operations experience both running and advising growth companies. Previously, he served as Global Operations Strategy Leader for PwC. During his tenure, he co-led the integration of his prior company, Booz & Company, following its acquisition by PwC. In his role, he grew operations into a global practice with $1.5 billion in revenue and 4,000 employees. His assignments focused on delivering structural cost improvements while also driving sustained revenue growth. His experience also includes roles at Booz Allen Hamilton, General Electric and AT&T. Alvarez holds a Master of Business Administration from Harvard Business School, a Master of Science in Mechanical Engineering in computer control and manufacturing from the University of California, Berkeley, and a Bachelor of Science degree in mechanical engineering from the University of Michigan. He is a board member of The Chicago Council of Global Affairs.

What is Eduardo Alvarez's net worth?: The estimated net worth of Eduardo Alvarez is at least $0.00 as of April 5th, 2023. Mr. Alvarez owns 612,546 shares of Amyris stock worth more than $0 as of November 22nd. This net worth estimate does not reflect any other assets that Mr. Alvarez may own. Additionally, Mr. Alvarez receives an annual salary of $687,620.00 as COO at Amyris. Learn More about Eduardo Alvarez's net worth.
How old is Eduardo Alvarez?: Mr. Alvarez is currently 59 years old. There are 3 older executives and no younger executives at Amyris. Learn More on Eduardo Alvarez's age.
What is Eduardo Alvarez's salary?: As the COO of Amyris, Inc., Mr. Alvarez earns $687,620.00 per year. Learn More on Eduardo Alvarez's salary.
How do I contact Eduardo Alvarez?: The corporate mailing address for Mr. Alvarez and other Amyris executives is 5885 HOLLIS STREET SUITE 100, EMERYVILLE CA, 94608. Amyris can also be reached via phone at (510) 450-0761 and via email at [email protected]. Learn More on Eduardo Alvarez's contact information.
Has Eduardo Alvarez been buying or selling shares of Amyris?: Eduardo Alvarez has not been actively trading shares of Amyris over the course of the past ninety days. Most recently, Eduardo Alvarez sold 231,368 shares of the business's stock in a transaction on Wednesday, April 5th. The shares were sold at an average price of $1.23, for a transaction totalling $284,582.64. Following the completion of the sale, the chief operating officer now directly owns 612,546 shares of the company's stock, valued at $753,431.58. Learn More on Eduardo Alvarez's trading history.
Who are Amyris' active insiders?: Amyris' insider roster includes Eduardo Alvarez (COO), Anthony Hughes (CAO), Nicole Kelsey (Insider), Hermanus Kieftenbeld (CFO), Frank Kung (Director), James McCann (Director), and John Melo (CEO). Learn More on Amyris' active insiders.

Eduardo Alvarez Insider Trading History at Amyris

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/5/2023	Sell	231,368	$1.23	$284,582.64	612,546
9/2/2021	Sell	17,605	$14.86	$261,610.30
12/13/2018	Buy	11,834	$4.23	$50,057.82	333,876
9/5/2018	Buy	11,877	$8.45	$100,360.65	331,877

Eduardo Alvarez Buying and Selling Activity at Amyris

Amyris Company Overview

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Today's Range

Now: N/A

50 Day Range

MA: $0.54

$0.05

$1.17

2 Week Range

Now: N/A

Volume

46,746,000 shs

Average Volume

12,593,118 shs

Market Capitalization

$18.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

What This Post-Election Shift Means for Your Investments

From InvestorPlace | Ad